Page last updated: 2024-12-07

acetyldeoxynivalenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID104759
CHEBI ID175302
MeSH IDM0116970

Synonyms (12)

Synonym
7,15-dihydroxy-8-oxo-12,13-epoxytrichothec-9-en-3-yl acetate
CHEBI:175302
acetyldeoxynivalenol
[3-hydroxy-2-(hydroxymethyl)-1,5-dimethyl-4-oxospiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-10-yl] acetate
wln: t c665 a ax ev io futj b1 c1q dq f1 kov1 lov1u2 a-& bt3ox chj
anguidine deriv 3a,15- dihydroxy-12,13-epoxytrichotec-9-en-8-one
trichothec-9-en-8-one,15-dihydroxy-, (3.alpha.,7.alpha.)-
trichothec-9-en-8-one, 12,13-epoxy-3,7,15-trihydroxy-, monoacetate, (3.alpha.,7.alpha.)-
ADFIQZBYNGPCGY-UHFFFAOYSA-N
115825-62-2
DTXSID50921817
PD044466

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The findings indicate that, after an initial period of reduced feed intake, animals are apparently able to overcome the toxic effects of 3-acetyldeoxynivalenol."( Subacute toxicity of dietary 3-acetyldeoxynivalenol in mice.
Blakley, BR; Greenhalgh, R; Hancock, DS; Kasali, OB; Schiefer, HB; Tomar, RS, 1985
)
0.76
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
trichotheceneAny one of a large family of chemically related mycotoxins with a structure based on a sesquiterpene skeleton. The most important structural features causing the biological activities of trichothecenes are a 12,13-epoxy ring, the presence of hydroxy or acetyl groups at appropriate positions on the trichothecene nucleus and the structure and position of the side-chain.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (20.83)18.7374
1990's2 (8.33)18.2507
2000's6 (25.00)29.6817
2010's9 (37.50)24.3611
2020's2 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.93 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index28.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]